发明申请
- 专利标题： CLARITHROMYCIN OR SALT THEREOF FOR USE IN THE TREATMENT OR PREVENTION OF PULMONARY DISEASE INDUCED BY DESTRUCTION OF PULMONARY ALVEOLI
- 专利标题（中）： 用于治疗或预防由破坏性血液病引起的肺部疾病的雷帕霉素或其盐
-
申请号： US11917845申请日： 2006-06-21
-
公开(公告)号： US20090088395A1公开(公告)日： 2009-04-02
- 发明人: Kiyoshi Takayama
- 申请人： Kiyoshi Takayama
- 申请人地址： JP Toshima-ku
- 专利权人： Taisho Pharmaceutical Co., Ltd.
- 当前专利权人： Taisho Pharmaceutical Co., Ltd.
- 当前专利权人地址： JP Toshima-ku
- 优先权： US11165201 20050624
- 国际申请： PCT/JP2006/312385 WO 20060621
- 主分类号： A61K31/7028
- IPC分类号： A61K31/7028 ; C07H17/08
摘要：
For the purpose of treatment and/or prevention of pulmonary disorders caused by the destruction of pulmonary alveoli resulting from smoking, air pollution, noxious gas, etc., there are provided, among others, a method of administering clarithromycin or a salt thereof to a mammal and a pharmaceutical composition comprising clarithromycin or a salt thereof.